These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331 [TBL] [Abstract][Full Text] [Related]
7. Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells. Desouza CV; Gerety M; Hamel FG Vascul Pharmacol; 2009; 51(2-3):162-8. PubMed ID: 19520186 [TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone antagonizes vascular endothelial growth factor signaling and nuclear factor of activated T cells activation in cardiac valve endothelium. Sander TL; Noll L; Klinkner DB; Weihrauch D; He BJ; Kaul S; Zangwill SD; Tweddell JS; Pritchard KA; Oldham KT Endothelium; 2006; 13(3):181-90. PubMed ID: 16840174 [TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer. Shigeto T; Yokoyama Y; Xin B; Mizunuma H Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343 [TBL] [Abstract][Full Text] [Related]
10. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium. Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081 [TBL] [Abstract][Full Text] [Related]
11. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600 [TBL] [Abstract][Full Text] [Related]
12. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice. Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand. Sarayba MA; Li L; Tungsiripat T; Liu NH; Sweet PM; Patel AJ; Osann KE; Chittiboyina A; Benson SC; Pershadsingh HA; Chuck RS Exp Eye Res; 2005 Mar; 80(3):435-42. PubMed ID: 15721625 [TBL] [Abstract][Full Text] [Related]
14. Tetrathiomolybdate blocks bFGF- but not VEGF-induced incipient angiogenesis in vitro. Mamou F; May KS; Schipper MJ; Gill N; Kariapper MS; Nair BM; Brewer G; Normolle D; Khan MK Anticancer Res; 2006; 26(3A):1753-8. PubMed ID: 16827103 [TBL] [Abstract][Full Text] [Related]
15. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia. Nagahama R; Matoba T; Nakano K; Kim-Mitsuyama S; Sunagawa K; Egashira K Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2427-34. PubMed ID: 22879581 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. Detoraki A; Staiano RI; Granata F; Giannattasio G; Prevete N; de Paulis A; Ribatti D; Genovese A; Triggiani M; Marone G J Allergy Clin Immunol; 2009 May; 123(5):1142-9, 1149.e1-5. PubMed ID: 19275959 [TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells. Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202 [TBL] [Abstract][Full Text] [Related]
19. Angiogenic activity of bFGF and VEGF suppressed by proteolytic cleavage by neutrophil elastase. Ai S; Cheng XW; Inoue A; Nakamura K; Okumura K; Iguchi A; Murohara T; Kuzuya M Biochem Biophys Res Commun; 2007 Dec; 364(2):395-401. PubMed ID: 17950695 [TBL] [Abstract][Full Text] [Related]
20. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism. Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]